CompletedNot Applicable

Development of an Informed Consent Statement Which Communicates the Risk of Adverse Events Associated With Dry Needling

United States5 participantsStarted 2022-09-19

Plain-language summary

As Dry Needling (DN) continues to see increased use in the clinic, there is a need to establish adverse events that could occur as a result of DN intervention. The adverse events are important to consider when an individual needs to make an informed decision regarding their care. It is important to consider how such information should be presented during the informed consent process to improve an individual's ability to make a sound decision regarding their own personal care.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Certification in Dry Needling
✓. Completion of a manual therapy fellowship that included dry needling training
✓. \>= 1 total scholarly product (poster presentation, author of a peer-reviewed publication) involving the use of dry needling
✓. Training in health law as evidenced by ONE of the following:
✓. Concentration/Certification in Health Law
✓. L.L.M in health or medical law
✓. SJD in health law
✓. Experience in litigating medical malpractice cases involving failure to obtain informed consent

What they're measuring

Demographic Information Form

Timeframe: Up to 2 hours

Ranking of Statements

Timeframe: A 2 hour virtual meeting for participants to rank statements

Trial details

NCT IDNCT05560100

SponsorYoungstown State University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-10-31

View on ClinicalTrials.gov More Dry Needling trials